Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Tom Brady Partners with eMed to Improve Access to GLP-1 Weight Loss Medications for Employers.
Jul 15, 2026
Contract Type
partnership
MiamiHealth Care
Description
Tom Brady has partnered with eMed to enhance access to GLP-1 weight loss medications aimed at addressing obesity in the United States. Through this partnership, eMed seeks to incentivize employers to provide these medications as a health benefit, emphasizing both health and financial advantages for companies.
Company Information
Company
eMed
Location
Miami, Florida, United States
About
eMed® is the world's first end-to-end GLP-1 care platform built on Empathetic AI™. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion.